The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
A pan-JAK inhibitor blocks IL-17A-induced TEER enhancement. (A) A... | Download Scientific Diagram
Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors - ScienceDirect
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Frontiers | Hi-JAKi-ng Synovial Fibroblasts in Inflammatory Arthritis With JAK Inhibitors
JAK inhibitors in dermatology: The promise of a new drug class. - Abstract - Europe PMC
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
JAK inhibitors and COVID-19 | Journal for ImmunoTherapy of Cancer
JAK Inhibitor 瑞石生物医药有限公司
Pharmaceuticals | Free Full-Text | Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies
The emerging safety profile of JAK inhibitors in rheumatic disease | Nature Reviews Rheumatology
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
Selective Janus kinase inhibitors come of age | Nature Reviews Rheumatology
皮膚科でのJAK阻害薬 | ひらぐん皮ふ科・アレルギー科
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
JAK Inhibitors: Prospects in Connective Tissue Diseases | SpringerLink
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology
A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal | Science Advances
Current and future status of JAK inhibitors - The Lancet
Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis - Wood - 2022 - International Journal of Dermatology - Wiley Online Library
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery
JAK inhibitors prevent JAK activation. The signaling cascade that... | Download Scientific Diagram
